AC
LKFT

AXQ Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AXQ Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Buy
+6,777
New +$224K 0.03% 742
2023
Q2 		– Sell
-5,389
Closed -$208K – 407
2023
Q1 		$208K Buy
+5,389
New +$222K 0.08% 399

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AXQ Capital's LKFT Position: Q1 2026 in Review

AXQ Capital opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 6,777 shares worth $203K. The stake represents 0.03% of the portfolio and ranks #742 among its holdings. This is a return to the name: AXQ Capital previously reported a position in LKFT as recently as Q1 2023.

AXQ Capital first reported a position in LKFT in Q1 2023 and has held it in 2 quarters since. The position peaked at $208K in Q1 2023. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • AXQ Capital held 6,777 shares of Lakefront Biotherapeutics American Depositary Shares worth $203K as of Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new AXQ Capital position in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.03% of AXQ Capital's portfolio in Q1 2026, its #742 holding.
  • AXQ Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and has held it in 2 quarters since.
  • AXQ Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $208K in Q1 2023.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.